Two isoforms of tissue transglutaminase mediate opposing cellular fates.
about
Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and deathProtein transamidation by transglutaminase 2 in cells: a disputed Ca2+-dependent action of a multifunctional proteinCellular functions of tissue transglutaminaseRole of transglutaminase 2 in celiac disease pathogenesisTransglutaminase 6: a protein associated with central nervous system development and motor function.Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells.Intracellular localization and conformational state of transglutaminase 2: implications for cell death.Transglutaminase 2, a novel regulator of eicosanoid production in asthma revealed by genome-wide expression profiling of distinct asthma phenotypesOpposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation.TGM2: a cell surface marker in esophageal adenocarcinomas.Type 2 transglutaminase in Huntington's disease: a double-edged sword with clinical potential.Transglutaminase 2: a molecular Swiss army knife.Tissue transglutaminase: a new target to reverse cancer drug resistanceRegulation of the activities of the mammalian transglutaminase family of enzymes.Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancerThe Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability.Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling.Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1Extracellular matrix modifications at fertilization: regulation of dityrosine crosslinking by transamidation.Transglutaminase activation in neurodegenerative diseases.Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.Evidences for a role of protein cross-links in transglutaminase-related disease.Transglutaminase as a therapeutic target for celiac disease.miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer.Interplay between transglutaminases and heparan sulphate in progressive renal scarring.Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer.Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy.GTP-binding-defective forms of tissue transglutaminase trigger cell death.Calcium-dependent activation of transglutaminase 2 by nanosecond pulsed electric fields.The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 Transglutaminase.Carbon monoxide modulates alpha-smooth muscle actin and small proline rich-1a expression in fibrosisTransglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.Transglutaminases: future perspectives.Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures.Deletion of 8q24 in an adult with mild dysmorphic features, developmental delay, and ketotic hypoglycemia.Role and predictive strength of transglutaminase type 2 expression in premalignant lesions of the cervix.Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family.
P2860
Q28069852-EAAFF552-FA2B-4C2E-9A4B-2C0F38863ACDQ28247511-29477AAB-7A86-45B1-BFEF-20783B6EF8B1Q28260600-509FC553-473F-462A-A698-EEEB7FD5D1C6Q28262529-9B8266B2-7863-4FFB-89E0-78FA52D8D981Q30155456-CB12AF9E-481D-4919-9AB4-95F280497A1FQ33289840-908A33D4-FBD8-49B0-BEDB-0DD2BD609F66Q33476870-37A87918-E09C-4E23-A9F2-BFEB25FF36ECQ33522235-7371EF5D-0BE4-4465-B14A-9CE8882851B1Q33661950-48339D1F-51F7-4511-B6D5-D2F149C698EAQ34219975-F3EC97DA-43CB-4690-B13A-6632A9B65358Q34775357-C5DAD1F9-C100-4893-93F1-63CD9CC75369Q35693361-3639A4C2-D967-415D-81E6-F02D3C344D90Q36503511-66EDCB9B-CC0E-47B9-BEFE-31B76B2FC473Q36620140-2DCBCB43-C4D7-45B9-8652-A594AA19D808Q36879220-DE1BBA7D-B374-4711-9DE5-221F4D27A166Q36884822-4E1B2E66-890D-420D-85E9-80A35DB27E37Q36916874-D1758AEB-B862-4BF6-BFF4-F36F6F58FB1EQ37124999-363C4A5B-C6C3-482F-9401-CEC4A1329925Q37186873-24078DEE-A0A0-4419-8680-B2821FBFCC26Q37352964-CDEB3F53-DA04-4EDF-A726-C8500DE37CF5Q37700761-0BD13721-A178-437E-880C-68D85933AF30Q37907975-BAF2353E-F61C-4E2D-92F0-7D79EF5EC277Q38269678-22BDE123-00CC-4D4A-A9AA-FE727ABF2EECQ38879949-973F611F-9BA3-4D8B-9885-8797D8B3BF53Q39330237-C2DC6807-7B57-41E9-93B1-CBE3BCF4D13FQ39442011-F8E4DCDB-49BF-47EC-BFE3-B6B1DFE61DE9Q39697142-72FF2E48-AB2C-4F17-8EB1-ED6596574D20Q40041960-C86B5E0E-21FE-4ABF-999A-018502A2DED1Q40981694-ADD64612-7C25-4E33-8E37-7322C18F061AQ41418352-D0A7E60C-EB47-4457-83CB-E6AABFDC3620Q41975551-912A03E4-317F-420F-95F4-7723AFA98FD2Q42403952-74B2F4F6-712C-46F8-A010-5B777D9457A7Q44811427-61B9B8F7-6DCE-4C1E-8FBF-58F237E094C7Q47099586-7A336EDC-B14D-400F-9F0F-A2546B77CA73Q51907616-3E31A481-4BD7-4C3A-86AD-A734C0655611Q54600809-58CD4EEF-DF2A-45D2-B435-36205D596A07Q55499802-8F76D248-D9E6-4E60-8511-2178AE349651
P2860
Two isoforms of tissue transglutaminase mediate opposing cellular fates.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Two isoforms of tissue transglutaminase mediate opposing cellular fates.
@ast
Two isoforms of tissue transglutaminase mediate opposing cellular fates.
@en
type
label
Two isoforms of tissue transglutaminase mediate opposing cellular fates.
@ast
Two isoforms of tissue transglutaminase mediate opposing cellular fates.
@en
prefLabel
Two isoforms of tissue transglutaminase mediate opposing cellular fates.
@ast
Two isoforms of tissue transglutaminase mediate opposing cellular fates.
@en
P2093
P2860
P356
P1476
Two isoforms of tissue transglutaminase mediate opposing cellular fates.
@en
P2093
Allison M Miller
Jaclyn M Jansen
Makoto Endo
Marc A Antonyak
Richard A Cerione
P2860
P304
18609-18614
P356
10.1073/PNAS.0604844103
P407
P577
2006-11-20T00:00:00Z